Author:
Bhuyan Prakash,Medin Jennie,da Silva Hugo Gomes,Yadavalli Madhavi,Shankar Nirmal Kumar,Mullerova Hana,Arnold Matthew,Nord Magnus
Reference5 articles.
1. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination;Greinacher;New Engl J Med,2021
2. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 20·6 million people in six European countries;Burn;medRxiv,2021
3. Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor;Eslamifar;Thromb J,2020
4. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial;Emary;Lancet,2021
5. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study;Bernal;BMJ,2021